Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Thai Chung who wrote (2891)	1/25/1999 8:49:00 AM
From: art slott	Read Replies (1) \| Respond to of 3725

I feel this is very positive. Imat satands to benefit, possibly significantly on the recapitalization of Positron. The ten units ordered by Japan is a nice suprise and the medicare reimbursement is the trump card. Art

To: Thai Chung who wrote (2891)	1/25/1999 9:43:00 PM
From: richard wilson	Read Replies (1) \| Respond to of 3725

They had to go and do it didn't they! Damn. I was really liking the way things were going with Imatron after sitting out for what must be a year now. Was waiting for a dip to jump back in. But no, they had to go and make another deal, just to throw a spanner in the works. They can't run imatron or heartscan (despite great product we are still not making positive earnings) and now they have another cake in the oven sucking out the heat that just began to grow. Oh well. Good luck to all, Richard.